TY - JOUR
T1 - European Society for Paediatric Endocrinology and European Society of Endocrinology Joint Clinical Practice Guidance for Healthcare Transition from Paediatric to Adult Endocrine Care
AU - Le Roux, Enora
AU - Stochholm, Kirstine
AU - Fassnacht, Martin
AU - Coyne, Imelda
AU - Touraine, Philippe
AU - Alexandraki, Krystallenia I.
AU - Wasniewska, Malgorzata
AU - van Eck, Judith P.
AU - Di Guisto, Victoria
AU - Helm, Amanda
AU - Valassi, Elena
AU - Marlier, Joke
AU - Cools, Martine
AU - Hamza, Rasha T.
AU - Aversa, Tommaso
AU - Isidori, Andrea M.
AU - Juul, Anders
AU - Verroken, Charlotte
AU - Ornstrup, Marie Juul
AU - Zabuliene, Lina
AU - Davidse, Kirsten
AU - Cianfarani, Stefano
AU - Neggers, Sebastian J.C.M.M.
N1 - © 2026 The Author(s). Published by S. Karger AG, Basel.
PY - 2026/2/19
Y1 - 2026/2/19
N2 - Background: The transition from paediatric to adult healthcare is a critical period for young individuals with endocrine conditions. Despite numerous published recommendations, Europe still lacks recent, comprehensive, evidence-based, and practically applicable guidelines for endocrine healthcare transition. Objective: The aim of the study was to develop European consensus guidance for transition from paediatric to adult care in endocrine conditions through a structured, evidence-based approach. Methods: A systematic literature review identified 351 recommendations from 55 articles (2011–2023). Articles were included if they provided recommendations on the transition from paediatric to adult care for patients with endocrine diseases or general (non-disease-specific) transition guidance. The guidance was developed by a core multidisciplinary group (n = 7) and refined through focus groups with 18 experts from 10 European countries, representing both paediatric and adult care settings. Patient representatives have reviewed and approved it. Results: The guidance includes recommendations across 11 domains: structure of transition service, patient empowerment, patient-professional relationship, multidisciplinary team organisation, healthcare provider education, timing and planning, care coordination, management of non-attendance, psychological support, parent/caregiver role, and readiness tools. Each recommendation was rated as either “recommend” (strong) or “suggest” (conditional) based on expert consensus and available evidence. Conclusion: This ESE-ESPE guidance provides a comprehensive, practical framework for endocrine healthcare transition, applicable across different European healthcare settings. The recommendations emphasise structured programs, care coordination, and patient-centred approaches to optimise transition outcomes.
AB - Background: The transition from paediatric to adult healthcare is a critical period for young individuals with endocrine conditions. Despite numerous published recommendations, Europe still lacks recent, comprehensive, evidence-based, and practically applicable guidelines for endocrine healthcare transition. Objective: The aim of the study was to develop European consensus guidance for transition from paediatric to adult care in endocrine conditions through a structured, evidence-based approach. Methods: A systematic literature review identified 351 recommendations from 55 articles (2011–2023). Articles were included if they provided recommendations on the transition from paediatric to adult care for patients with endocrine diseases or general (non-disease-specific) transition guidance. The guidance was developed by a core multidisciplinary group (n = 7) and refined through focus groups with 18 experts from 10 European countries, representing both paediatric and adult care settings. Patient representatives have reviewed and approved it. Results: The guidance includes recommendations across 11 domains: structure of transition service, patient empowerment, patient-professional relationship, multidisciplinary team organisation, healthcare provider education, timing and planning, care coordination, management of non-attendance, psychological support, parent/caregiver role, and readiness tools. Each recommendation was rated as either “recommend” (strong) or “suggest” (conditional) based on expert consensus and available evidence. Conclusion: This ESE-ESPE guidance provides a comprehensive, practical framework for endocrine healthcare transition, applicable across different European healthcare settings. The recommendations emphasise structured programs, care coordination, and patient-centred approaches to optimise transition outcomes.
KW - Adolescent
KW - Clinical practice guidelines
KW - Endocrine conditions
KW - Healthcare transition
KW - Young adult
UR - https://www.scopus.com/pages/publications/105034305213
U2 - 10.1159/000550744
DO - 10.1159/000550744
M3 - Article
C2 - 41712477
AN - SCOPUS:105034305213
SN - 1663-2818
SP - 1
EP - 11
JO - Hormone research in paediatrics
JF - Hormone research in paediatrics
ER -